Pens and prospering as a manufacturer

Pens and prospering as a manufacturer

November 18, 2019

Melbourne, Victoria, Australia

Trajan Scientific and Medical (Trajan) has been featured by @AuManufacturing, highlighting Trajan's ongoing investment into the development of hemaPEN®, and other technologies to address emerging trends in healthcare.

The article outlines Trajan's collaborative approach to R&D, and success in identifying and manufacturing niche technologies for global markets.

Read the full article at @AUManufacturing - Pens and prospering as a manufacturer.

More information
hemaPEN
About us
@AuManufacturing

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com

The hemaPEN® is a device supplied for research purposes only. This device is not for therapeutic or diagnostic use.




Also in News

Trajan Scientific and Medical continues its focus on Microsampling
Trajan Scientific and Medical continues its focus on Microsampling

April 20, 2022

Trajan Scientific and Medical, (Trajan, ASX:TRJ) partnered with researchers at The University of Queensland to develop a skin microbiopsy device which takes tissue samples smaller than 0.5mm in diameter.  It can be used to collect biopsies for skin conditions, including skin cancers.

Read More

Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit
Cathy Cordova Appointed Trajan's General Manager of Microsampling Unit

February 16, 2022

Cathy Cordova has been appointed the General Manager of the consolidated Microsampling Business Unit for Trajan Scientific and Medical.

Read More

Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.
Dr Xumei Gao (Bryan) awarded REDI fellowship to partner with Trajan.

January 27, 2022

 Dr Xumei Gao (Bryan) a Postdoctoral Researcher from the ARC Training Centre for Personalized Therapeutics Technologies at the University of Melbourne, has been awarded a REDI fellowship to partner with Trajan.

Read More